← Open Payments lookup

KIM GUSTAFSON: Open Payments

NPI 1164896056 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$517 in 27 payments from 10 companies in 2025. Trend: 2023 $1,099 · 2024 $893 · 2025 $517

Food & beverage: $517
CompanyPaymentsAmount
Sumitomo Pharma America, Inc.6$135
MILLICENT US INC5$86
Exeltis, USA Inc.4$63
Bausch Health US, LLC2$50
Currax Pharmaceuticals LLC3$48
MAYNE PHARMA COMMERCIAL LLC3$42
Organon LLC1$30
Astellas Pharma US Inc1$25
Exact Sciences Corporation1$20
CooperSurgical, Inc.1$17

Products named: MYFEMBREE, SLYND, APLENZIN, FEMLYV, CONTRAVE, FEMRING, NEXPLANON, Veozah.

Industry payments across TX — which companies pay providers there.